ISRCTN ISRCTN96901396
DOI https://doi.org/10.1186/ISRCTN96901396
Secondary identifying numbers KSC 02/2003
Submission date
16/12/2003
Registration date
22/12/2003
Last edited
02/10/2017
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Surgery
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Markus W Büchler
Scientific

University of Heidelberg Medical School
Im Neuenheimer Feld 110
Heidelberg
69120
Germany

Phone +49 6221 56 6200
Email Markus_Buechler@med.uni-heidelberg.de

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Scientific titleClips versus Ligatures in Thyroid Surgery: a randomised controlled trial
Study acronymCLIVIT-Trial
Study objectivesTo date, no clear scientific recommendation exists in regard to the available blood vessel ligation techniques in thyroid surgery. A systematic review comparing different blood vessel ligation techniques has not yet been performed. The literature on this topic shows several deficits thus reducing its internal and external validity. Main problems are underpowered sample sizes, missing data in regard to the surgical technique, lack of standardization of the various surgical techniques and of homogeneity of the used study designs.

Therefore a randomized controlled multicenter, patient-blinded, two-group parallel relevance study under standardized conditions is required in order to achieve high internal as well as external validity. This would allow the results to be generalized for thyroid surgery and also may have implications for other surgical settings. This study is one of the first studies designed and organized by the Study Center of the German Surgical Society (SDGC). Besides investigating the primary hypothesis, this study was also started with the aim of developing a nationwide structure for randomized trials using a common and surgical relevant procedure.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedThyroid surgery
InterventionThe standard surgical approach in both treatment groups will be the Dunhill-Procedure which consists of a hemithyroidectomy and a subtotal thyroidectomy (at least 2/3 of the gland). The randomisation will proceed when the thyroid gland has been exposed and the decision in favour of a Dunhill procedure is made. Initially the vessels of the upper pole of the thyroid (hemithyroidectomy side) are localised and dissected from medial. Afterwards they are ligated with the conventional clamp-tie technique (Novafil 3-0 or equivalent monofilament suture type). Time is measured from ligating the vessels of the upper pole to the removal of the complete specimen. All vessels except the upper pole vessels of both sides are ligated according to the randomised technique: either using the clip vessel ligation technique or occluding manually by single ligatures (Vicryl 3-0).
Intervention typeProcedure/Surgery
Primary outcome measureThe primary objective of this study is to test whether there is a relevant reduction in operating time (>15 min), using the clip vessel occluding technique versus the conventional clamp-tie.
Secondary outcome measuresSecondary objectives are divided into surgical and non-surgical categories. In the surgical category there are the following points: total duration of operation (skin incision until suture), weight of specimen, amount of postoperative bleeding, frequency of reoperation due to bleeding, recurrent laryngeal nerve paralysis (temporary or irreversible – pre- and postoperative assessment of vocal cord function by ENT-specialist), wound infection rate and rate of impaired parathyroid gland function. The non-surgical category consists of duration of postoperative hospital stay.

To assess the relevance of the chosen endpoints, the following ten aspects have to be ranked from "most important" to "least important" by patients and surgeons (only once): Intraoperative complications, postoperative complications, length of hospital stay, voice function, dysphagia, death, postoperative pain, postoperative fatigue, convalescence of complete physical maximum resilience and cosmetic result.
Overall study start date05/03/2004
Completion date31/12/2008

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participants420
Key inclusion criteriaThe trial population consists of hospitalised patients of the four participating Departments of Surgery, who are planned for an elective thyroid operation. These operations can be performed with either the clip vessel ligation technique or the conventional clamp-tie technique.

At study enrollment:
• Age equal or greater than 18 years
• Expected survival time more than 12 months
• Patients with benign diseases of the thyroid gland scheduled for elective surgery
• Euthyroid metabolism (normal level of TSH or T3/T4)
• Normal function of the vocal cords
• Informed consent

At the end of surgical exploration:
• Suitable for at least 2/3 resection of the thyroid
Key exclusion criteriaMalignant disease or high suspicion for malignancy (clinical and imaging evidence)
Nerve palsy
Graves' Disease
Coagulopathy
Current immunosuppressive therapy
Chemotherapy within 2 weeks before operation
Radiotherapy completed no longer than 8 weeks before operation
Severe psychiatric or neurologic disease
Drug- and/or alcohol-abuse
Participation in another intervention-trial with interference of intervention and outcome
Inability to follow the instructions given by the investigator or the telephone interviewer
Lack of compliance
Date of first enrolment05/03/2004
Date of final enrolment31/12/2008

Locations

Countries of recruitment

  • Germany

Study participating centre

University of Heidelberg Medical School
Heidelberg
69120
Germany

Sponsor information

University of Heidelberg Medical School (Germany)
University/education

Im Neuenheimer Feld 110
Heidelberg
69120
Germany

Phone +49 6221 56 6200
Email Markus_Buechler@med.uni-heidelberg.de
ROR logo "ROR" https://ror.org/038t36y30

Funders

Funder type

Other

Grant from the German Ministry of Research and Education and supported by the BBD-Aesculap© Company, Tuttlingen, Germany

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Protocol article protocol 01/09/2006 Yes No
Results article results 01/10/2012 Yes No

Editorial Notes

02/10/2017: internal review.